150-200 LVV
cGMP clinical and commercial batches manufactured annually .
20+ Years of GMP Experience
We began manufacturing viral vectors in the early 2000s in Houston, Texas.
>70 Process Development Projects
We have an extensive track-record of development services for viral-vector customers.

Our high level of expertise across the range of adherent and suspension Lentiviral Vector (LVV) production methods provides you with the flexibility to transition across methods and scale up your production when it suits you.


A standardized, systematic approach from concept to commercialization

An established, global quality and regulatory infrastructure for process development, tech transfers, GMP manufacturing and pre-license inspection readiness

A scalable, Robust & Streamlined Platform with High LVV Productivity

Demonstrated performance with multiple Genes Of Interests (GOIs)

Comprehensive analytics

Enables efficient identification of process inefficiencies and subsequent optimization.

Provides high confidence in quantifying LVV attributes through multiple orthogonal assays.

Extensive commercial manufacturing experience for LVV production

We currently produce hundreds of cGMP batches per year for our late-clinical and commercial customers

Our LVV suspension platform

High LVV productivity using our proprietary clonal cell line, comprehensive analytics and streamlined upstream and downstream process.

Our location

Houston – a home with room to grow approved for commercial manufacturing


Our 300,000 square-feet dedicated cell and gene therapy facility in Houston, Texas is designed by experts in cell and gene therapy to address the key challenges in the manufacturing of these therapies and the critical product supply needs of our customers.

The world’s largest dedicated cell and gene therapies manufacturing facility at the time of opening in 2018, our Houston site is now approved for commercial manufacture.

The modular designed cleanroom can be custom built to fit our client process needs in the existing shell space with a cost-effective and time-efficient manner. Working side-by-side with our clients in the product development life-cycle, we can de-risk your path to commercialization together, from developing regulatory-compliant industrialized process to securing cGMP capacities to meet market demand.

Learn more